P. J. Guillausseau, Type II diabetes mellitus: an update on diagnosis, classification and pathogenesis of the disease. Sang Thrombose Vaisseaux, pp.658-63, 2000.

G. Shulman, Cellular mechanisms of insulin resistance, Journal of Clinical Investigation, vol.106, issue.2, pp.171-177, 2000.
DOI : 10.1172/JCI10583

B. Kahn and J. Flier, Obesity and insulin resistance, Journal of Clinical Investigation, vol.106, issue.4, pp.473-481, 2000.
DOI : 10.1172/JCI10842

. Association-canadienne-du-diabète, Lignes directrices de pratique clinique 2008 de l'Association canadienne du diabète pour la prévention et le traitement du diabète au Canada, Can J Diabet, 2008.

C. Management-institute and K. Permanente, Adult diabetes clinical practice [complete summary

S. Ghosh, A. Collier, and T. Elhadd, Retinopathy in prediabetes, The British Journal of Diabetes & Vascular Disease, vol.10, issue.3, p.155, 2010.
DOI : 10.1177/1474651409361427

S. Tesfaye, N. Chaturvedi, and S. Eaton, Vascular Risk Factors and Diabetic Neuropathy, New England Journal of Medicine, vol.352, issue.4, pp.341-350, 2005.
DOI : 10.1056/NEJMoa032782

G. Reiber, E. Boyko, and D. Smith, Lower extremity foot ulcers and amputations in diabetes In: Diabetes in America, MD: National Diabetes Data Group, pp.409-428

J. Puel, P. Valensi, and G. Vanzetto, Identification de l'ischémie myocardique chez le diabétique. Recommandations conjointes Société Française de Cardiologie / Association de langue française pour l'étude du diabète et des maladies métaboliques, Arch Mal Coeur Vaisseaux, vol.97, issue.4, pp.338-57, 2004.

J. Tuomilheto, J. Lindström, and J. Eriksson, Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance, New England Journal of Medicine, vol.344, issue.18, pp.1343-50, 2001.
DOI : 10.1056/NEJM200105033441801

F. Pi-sunyer, C. Maggio, and D. Mccarron, Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes, Diabetes Care, vol.22, issue.2, pp.191-197, 1999.
DOI : 10.2337/diacare.22.2.191

M. Franz, A. Monk, and B. Barry, Effectiveness of Medical Nutrition Therapy Provided by Dietitians in the Management of Non???Insulin-Dependent Diabetes Mellitus, Journal of the American Dietetic Association, vol.95, issue.9, pp.1009-1017, 1995.
DOI : 10.1016/S0002-8223(95)00276-6

X. Pan, G. Li, and Y. Hu, Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study, Diabetes Care, vol.20, issue.4, pp.537-581, 1997.
DOI : 10.2337/diacare.20.4.537

N. Snowling and W. Hopkins, Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: A meta-analysis, Diabetes Care, vol.29, issue.11, pp.2518-2527, 2006.
DOI : 10.2337/dc06-1317

C. Moy, T. Songer, and R. Laporte, Insulin-dependent Diabetes Mellitus, Physical Activity, and Death, American Journal of Epidemiology, vol.137, issue.1, pp.74-81, 1993.
DOI : 10.1093/oxfordjournals.aje.a116604

C. Castaneda, J. Layne, and L. Munoz-orians, A Randomized Controlled Trial of Resistance Exercise Training to Improve Glycemic Control in Older Adults With Type 2 Diabetes, Diabetes Care, vol.25, issue.12, pp.2335-2341, 2002.
DOI : 10.2337/diacare.25.12.2335

J. Chiasson, R. Josse, and J. Hunt, The Efficacy of Acarbose in the Treatment of Patients with Non???Insulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial, Annals of Internal Medicine, vol.121, issue.12, pp.928-935, 1994.
DOI : 10.7326/0003-4819-121-12-199412150-00004

R. Holman, C. Cull, and R. Turner, A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) Diabetes Care, pp.960-964, 1999.

S. Schwartz, Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes, Diabetes Care, vol.29, issue.4, 2006.
DOI : 10.2337/diacare.29.04.06.dc05-1967

R. Defronzo and M. Goodman, Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus, New England Journal of Medicine, vol.333, issue.9
DOI : 10.1056/NEJM199508313330902

S. Aronoff, S. Rosenblatt, and S. Braithwaite, Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group, Diabetes Care, vol.23, issue.11, pp.1605-1611, 2000.
DOI : 10.2337/diacare.23.11.1605

H. E. Lebovitz, J. F. Dole, and R. Patwardhan, Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.1, pp.280-288, 2001.
DOI : 10.1210/jcem.86.1.7157

L. Phillips, G. Grunberger, and E. Miller, Once- and Twice-Daily Dosing With Rosiglitazone Improves Glycemic Control in Patients With Type 2 Diabetes, Diabetes Care, vol.24, issue.2, pp.308-315, 2001.
DOI : 10.2337/diacare.24.2.308

D. Einhorn, M. Rendell, and J. Rosenzweig, Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: A randomized, placebo-controlled study, Clinical Therapeutics, vol.22, issue.12, pp.1395-409, 2000.
DOI : 10.1016/S0149-2918(00)83039-8

M. Kipnes, A. Krosnick, and M. Rendell, Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study, The American Journal of Medicine, vol.111, issue.1, pp.10-17, 2001.
DOI : 10.1016/S0002-9343(01)00713-6

G. Daily, M. Noor, J. Soon, and P. , Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial, The American Journal of Medicine, vol.116, issue.4, pp.223-229, 2004.
DOI : 10.1016/j.amjmed.2003.07.022

S. Kahn, S. Haffner, and M. Heise, Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy, New England Journal of Medicine, vol.355, issue.23, pp.2427-2470, 2006.
DOI : 10.1056/NEJMoa066224

A. Harrower, Gliclazide modified release: From once-daily administration to 24-hour blood glucose control, Metabolism, vol.49, issue.10, pp.7-11, 2000.
DOI : 10.1053/meta.2000.17823

. Group, Relative efficacy of randomly allocated diet, sulphonyl-urea, insulin or metformin in newly diagnosed non-insulin dependent diabetes followed for 3 years.(UKPDS 13), BMJ, vol.310, pp.83-90, 1995.

V. Gaal and L. Van-acker-kl, Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes, Diabetes Research and Clinical Practice, vol.53, issue.3, pp.141-149, 2001.
DOI : 10.1016/S0168-8227(01)00253-4

L. Jovanovic, I. G. Dailey, and W. Huang, Repaglinide in Type 2 Diabetes: A 24-Week, Fixed-Dose Efficacy and Safety Study, Journal of Clinical Pharmacology, vol.40, issue.1, pp.49-57, 2000.
DOI : 10.1177/00912700022008694

R. Goldberg, D. Einhorn, and C. Lucas, A randomized placebo-controlled trial of repaglinide in the treatment of type 2 diabetes, Diabetes Care, vol.21, issue.11, pp.1897-903, 1998.
DOI : 10.2337/diacare.21.11.1897

L. Blonde, Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes, Diabetes, Obesity and Metabolism, vol.22, issue.4, pp.436-483, 2006.
DOI : 10.1046/j.1462-8902.2001.00038.x

M. Polster, E. Zanutto, S. Mcdonald, C. Conner, and M. Hammer, A comparison of preferences for two GLP-1 products ??? liraglutide and exenatide ??? for the treatment of type 2 diabetes, Journal of Medical Economics, vol.13, issue.4, 2010.
DOI : 10.3111/13696998.2010.529377

E. Bosi, R. Camisasca, and C. Collober, Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin, Diabetes Care, vol.30, issue.4, pp.890-895, 2007.
DOI : 10.2337/dc06-1732

P. Aschner, M. Kipnes, and J. Lunceford, Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes, Diabetes Care, vol.29, issue.12, pp.2632-2637, 2006.
DOI : 10.2337/dc06-0703

E. Bosi, R. Camisasca, and C. Collober, Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin, Diabetes Care, vol.30, issue.4, pp.890-895, 2007.
DOI : 10.2337/dc06-1732

P. Aschner, M. Kipnes, and J. Lunceford, Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes, Diabetes Care, vol.29, issue.12, pp.2632-2637, 2006.
DOI : 10.2337/dc06-0703

G. Levasseur, Réseaux et éducation du patient : des conditions préalables à l'action. Éducation du Patient et Enjeux de Santé, pp.21-25, 2002.

J. Foucaud, J. A. Bury, and M. Balcou-debussche, Éducation thérapeutique du patient. Modèles, pratiques et évaluation. Saint-Denis : Inpes, coll. Santé en action, p.412, 2010.

. 114-rapport-de-l-'oms-europe, Therapeutic Patient Education ? Continuing Education Programmesfor Health Care Providers in the field of Chronic Disease, traduit en français en, 1996.

G. Lagger, M. Chambouleyron, and A. Lasserre-moutet, Education thérapeutique ; 1ère partie : origines et modèle, Médecine, vol.2008, pp.223-249

V. Coliche, J. Kulik, and M. Vamouille, Programme d'amélioration de la prise en charge et de la qualité de vie des diabétique de type 2. http://www.has-sante.fr/portail, pp.2010-2016, 2010.

. Résumé-n°045, -session posters http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-04/symphas-bmj_po045.pdf -Consulté en « Mai, Symposium HAS-BMJ, p.168, 2010.

J. Wihelm, S. Moser, and C. Weigel, Prise en charge du diabète : expérience du réseau santé de Haute Alsace http://www.has-sante.fr/portail, p.180, 2010.

/. Pdf and /. 11415_01, Questionnaire de satisfaction des patients httppdf -Consulté en « Janvier 2010 » 182 kalitis web site ? URL : Kalitis stratégie et outils de pilotage : Questionnaire de satisfaction du patient http://kalitis.com/questionnaire-maternite.pdf -Consulté en « Janvier 2010 » 183 alsacap web site ? URL : Document réservé à l'usage du Réseau ALSACEP. Questionnaire d'évaluation de satisfaction des patients atteint de sclérose en plaques, QUESTIONNAIRE1.pdf -Consulté en « Janvier 2010 » 184 clinique-mousseau web site ? URL : Questionnaire de satisfaction patient en maternité http

C. Notre-dame-de-la and M. , Questionnaire satisfaction patient http://www.clinique-ndm.com/hospiform.htm -Consulté en « Janvier 2010 » 187 Lesdiabetiques.com web site ? URL : Derniers sondages. http://www.lesdiabetiques.com/modules.php?name=Surveys ? Consulté en « Janvier 2010 » 188 INDE web site ? URL : Population de la France au 1 er janvier, 2010.

P. Ricordeau, A. Weill, and N. Vallier, Epidemiology of diabetes in metropolitan France, Diabetes Metab, vol.26, issue.6, pp.11-24, 2000.

O. Obésité, Prévention et prise en charge de l'épidémie mondiale, 2003.

J. F. Gautier, C. Berne, and J. J. Grimm, Activité physique et diabète Recommandations de l'ALFEDIAM http://www.alfediam.org/membres/recommandations/alfediam-sportdiabete.asp Consulté en " Novembre, p.197, 1998.

B. Charbonnel, B. Bouhanick, L. Feuvre, and C. , Recommandations SFC / ALFEDIAM sur la prise en charge du patient diabétique vu par le cardiologue http://www.alfediam.org/membres/recommandations/recos_sfc_alfediam.pdf Consulté en « Novembre, ars.sante web site ? URL, 0198.

. Les-procédures-d, autorisation des programmes d'éducation thérapeutique du patient (ETP) http://www.ars.sante.fr/Les-procedures-d-autorisation.98009.0.html -Consulté en « Novembre, TABLE DES ANNEXES, 2010.

C. .. De-grenoble, Annexe 1 : Charte éthique des programmes d'éducation thérapeutique, p.174

E. Possibilité-À, de faire à postériori l'analyse de la nature, du type de registre des objectifs convenus avec les patients (exemple 35 objectifs dans le registre alimentaire

P. Hba1c, évolution du traitement médicamenteux à 6 et 12 mois par exemple ? Intéressant de noter combien d'appels téléphoniques ont été nécessaire pour recueillir les résultats d'HbA1c. Evaluer si augmentation du nombre d'analyses d'HbA1c réalisées par rapport à la littérature